Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Redox Limited (RDX.AX)
Minto, NSW, AU
Established in 1965 and based in Minto, Australia, Redox Limited is a global provider and distributor of essential chemicals, ingredients, and raw materials. Its operations span Australia, New Zealand, the United States, and numerous other international regions. The company's comprehensive product catalog serves a multitude of industries, offering everything from food additives (like proteins, sweeteners, and thickeners), vitamins, and amino acids for the food and beverage and human health sectors, to animal feed supplements, fertilizers, and crop protection agents for agriculture. For personal care and hygiene, Redox supplies emollients, sunscreens, and surfactants. Industrial applications are met with a broad selection of solvents, processing aids, waxes, and specialized chemicals for surface coatings, textiles, lubricants, and mining. Furthermore, Redox provides critical solutions for water treatment, including pool chemicals, pH adjusters, and biocides, as well as construction materials like roading additives, gypsum, concrete admixtures, and insulation components. Its diverse clientele includes businesses in detergents, metals, building and construction, oil and gas, rubber, plastics, and foam manufacturing.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +9.06% | +9.06% | -0.61% | +1.25% | +12.07% | +6.91% | +17.33% | +34.30% | +34.30% | +34.30% | +34.30% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+9.4% ★ Q4'25: +15.8% (vs Q4'23)
-
EPS growth Chemicals: +11.7%-11.8% Q4'25: +10.3% (vs Q4'23)
-
FCF margin FCF growth · Chemicals: +41.7%+2.9% Q4'25: +8.8% (vs Q4'23)
-
EBIT margin Chemicals: +7.1%+9.0% ★ Q4'25: +10.8% (vs Q4'23)
-
ROIC Chemicals: +3.4%+16.6% ★ Q4'25: +42.4% (vs Q4'23)
-
Share dilution Chemicals: +0.0%+0.2% Q4'25: +0.2% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×0.41× ★ Q4'25: 0.22× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 4 Rev. Ana. 3 EPS Ana. |
Jun 2027 4 Rev. Ana. 3 EPS Ana. |
Jun 2028 4 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
1.26B
est: 1.25B (+0.7%)
|
1.14B
est: 1.21B (-5.9%)
|
1.24B
est: 1.23B (+1.0%)
|
1.36B
1.35B – 1.36B
+10.1% YoY
|
1.51B
1.48B – 1.55B
+11.2% YoY
|
1.66B
1.66B – 1.67B
+10.2% YoY
|
| EBITDA |
137.07M
est: 138.97M (-1.4%)
|
138.42M
est: 134.57M (+2.9%)
|
122.94M
est: 137.16M (-10.4%)
|
151.07M
149.96M – 151.69M
+10.1% YoY
|
167.98M
164.57M – 172.15M
+11.2% YoY
|
185.15M
184.61M – 185.70M
+10.2% YoY
|
| EBIT |
127.91M
est: 129.69M (-1.4%)
|
130.00M
est: 125.59M (+3.5%)
|
112.45M
est: 128.00M (-12.1%)
|
140.99M
139.95M – 141.56M
+10.1% YoY
|
156.76M
153.58M – 160.65M
+11.2% YoY
|
172.79M
172.28M – 173.30M
+10.2% YoY
|
| Net Income |
80.73M
est: 82.58M (-2.2%)
|
90.24M
est: 93.91M (-3.9%)
|
77.10M
est: 77.10M (+0.0%)
|
82.88M
79.83M – 92.61M
+7.5% YoY
|
99.92M
89.87M – 111.53M
+20.6% YoY
|
114.35M
102.25M – 119.12M
+14.4% YoY
|
| SGA |
110.11M
est: 122.65M (-10.2%)
|
113.86M
est: 118.77M (-4.1%)
|
131.83M
est: 121.05M (+8.9%)
|
133.33M
132.35M – 133.88M
+10.1% YoY
|
148.25M
145.24M – 151.93M
+11.2% YoY
|
163.41M
162.93M – 163.89M
+10.2% YoY
|
| EPS |
0.19
est: 0.16 (+21.0%)
|
0.17
est: 0.18 (-4.7%)
|
0.15
est: 0.14 (+5.2%)
|
0.16
0.15 – 0.18
+15.0% YoY
|
0.18
0.17 – 0.21
+11.8% YoY
|
0.21
0.19 – 0.23
+11.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares S&P/ASX Small Ordinaries ETF ISO.AX | 0.26% | 229.4K | 0.55% |
| 2 | iShares Edge MSCI Australia Multifactor ETF AUMF.AX | 0.13% | 123.5K | 0.30% |
| 3 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.12% | 508.6K | 0.48% |
| 4 | Vanguard MSCI Australian Small Companies Index ETF VSO.AX | 0.11% | 842.8K | 0.30% |
| 5 | WisdomTree International SmallCap Dividend Fund DLS | 0.11% | 1.10M | 0.58% |
| 6 | WisdomTree International High Dividend Fund DTH | 0.06% | 402.0K | 0.58% |
| 7 | Vanguard Australian Shares High Yield ETF VHY.AX | 0.05% | 2.85M | 0.25% |
| 8 | Vanguard Australian Shares Index ETF VAS.AX | 0.02% | 4.19M | 0.07% |
| 9 | Avantis International Small Cap Equity ETF AVDS | 0.02% | 66.4K | 0.30% |
| 10 | Schwab International Small-Cap Equity ETF SCHC | 0.02% | 900.2K | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Raimond Coneliano | Chief Executive Officer, MD & Executive Director | 809.9K | male |
| Renato Coneliano | Marketing Director & Executive Director | 539.8K | male |
| Kim Yap | Chief Financial Officer | 466.9K | male |
| Richard Coneliano | Chief Operating Officer | 413.6K | male |
| Erika Jasarevic | General Counsel & Company Secretary | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RDX.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
